Abbvie Inc (NYSE:ABBV) traded at $159.25 at last check on Monday, April 29, made a downward move of -0.23% on its previous day’s price.
Looking at the stock we see that its previous close was $159.62. The company has a trailing 12-month PE ratio of 47.34. In terms of its 52-week price range, ABBV has a high of $182.89 and a low of $130.96. The company’s stock has lost about -12.55% over that past 30 days.
Abbvie Inc has a market cap of $281.98 billion. With its Forward Dividend at 6.06 and a yield of 3.81%, the company’s investors could be anxious for the ABBV stock to gain ahead of the earnings release.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ABBV stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of Hold.
Looking further, we note that the PEG ratio for the ABBV stock currently stands at 7.47, and the most recent price level today is -5.41% off its SMA20 and -8.73% from its 50-day simple moving average. The RSI (14) is pointing at 30.92 while the volatility over the past week is 2.55% and jumps to 2.16% over the past one month. The beta value is 0.59, while the average true range (ATR) is currently pointing at 3.65.
Coming back to Abbvie Inc (NYSE:ABBV), we note that the average 3-month trading volume was 5.71 million. Current shares outstanding are 1.77 billion.
The insiders hold 0.11% of the company’s shares while institutions hold 71.55%. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 2.76% up in year-to-date price movement.
